Source: MarketScreener

Eli Lilly: Eli Lilly and : Lilly to Participate in Guggenheim Biopharma Strategy Series

( INDIANAPOLIS, June 14, 2021 /PRNewswire/ -- Eli Lilly and Company will participate in the Guggenheim Biopharma Strategy Series - Biopharma's Next Decade: Views from the Top on Global Strategy and Innovation - on Friday, June 18, 2021. Daniel Skovronsky, M.D., Ph.D., Lilly's Chief Scientific and Medical Officer and President of...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
David A. Ricks's photo - Chairman & CEO of Eli Lilly

Chairman & CEO

David A. Ricks

CEO Approval Rating


Read more